+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary Intravenous (IV) Solutions Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 111 Pages
  • July 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5867928
Description Jump to:
The veterinary intravenous (IV) solutions market is projected to grow at a CAGR of 5.5% during the forecast period of 2023 to 2031, driven by factors such as increasing awareness about animal healthcare, growing adoption of pets, and advancements in veterinary medicine. Veterinary IV solutions play a vital role in providing essential fluids, nutrients, and medications to animals through intravenous administration. These solutions are widely used in veterinary clinics, hospitals, and research facilities to support animal health and recovery. Factors such as increasing awareness of animal healthcare, advancements in veterinary medicine, rising pet adoption rates, and the economic and medical benefits of IV solutions contribute to the market's expansion. However, addressing quality and safety concerns is critical to sustaining growth and fostering confidence among veterinarians and pet owners in the efficacy of veterinary IV solutions. As the bond between humans and animals continues to strengthen, the demand for high-quality veterinary IV solutions is expected to witness a positive trajectory.

Growing Awareness of Animal Healthcare

The rising awareness of animal healthcare and the importance of timely treatment are significant drivers behind the growth of the Veterinary IV Solutions market. Pet owners and veterinarians are increasingly recognizing the benefits of intravenous therapy for animals suffering from dehydration, electrolyte imbalances, and critical medical conditions. As pet ownership becomes more prevalent and the bond between humans and animals strengthens, the demand for high-quality veterinary IV solutions is expected to increase.

Advancements in Veterinary Medicine

Advancements in veterinary medicine, including improvements in intravenous therapies and medical equipment, are propelling the growth of the Veterinary IV Solutions market. Veterinary IV solutions are now available in various formulations to cater to the specific needs of different animal species and medical conditions. The development of innovative IV delivery systems and infusion pumps has enhanced the accuracy and safety of administering IV solutions to animals, contributing to the market's expansion.

Rising Pet Adoption Rates

The growing trend of pet adoption, coupled with increasing expenditure on pet healthcare, is driving the demand for Veterinary IV Solutions. As more families and individuals adopt pets and treat them as integral members of their households, the need for advanced veterinary care, including intravenous therapy, has surged. The Veterinary IV Solutions market is benefiting from this trend as veterinarians strive to provide optimal medical care to their patients.

 Economic and Medical Benefits of Veterinary IV Solutions

The economic and medical benefits of using veterinary IV solutions act as additional drivers for the market. Intravenous therapy is an effective and efficient way to deliver fluids, medications, and nutrients directly into an animal's bloodstream, ensuring rapid absorption and distribution throughout the body. Veterinary IV solutions aid in the treatment of conditions like dehydration, shock, and nutritional deficiencies, leading to faster recovery and improved overall health. Moreover, the judicious use of IV solutions can potentially reduce the need for prolonged hospitalization, lowering healthcare costs for pet owners.

Quality and Safety Concerns

A significant consideration in the Veterinary IV Solutions market is ensuring the quality and safety of the products. Veterinarians and pet owners rely on the purity and efficacy of IV solutions to provide the best care for animals. Contamination and impurities in IV solutions can pose risks to animal health and hinder treatment outcomes. Therefore, maintaining stringent quality control measures and adhering to industry standards is essential for manufacturers and suppliers of veterinary IV solutions. Rigorous testing and proper manufacturing techniques are crucial to mitigating quality concerns and ensuring the safety of IV solutions used in veterinary practices.

Product Segment: Fluid Therapy Solutions Dominates the Market

The Veterinary Intravenous (IV) Solutions market can be segmented based on the product types, which categorize the IV solutions according to their formulations and compositions. The key product segments include Fluid Therapy Solutions, Electrolyte Solutions, Nutritional Solutions, Blood and Plasma Substitutes, and Others. Among these segments, Fluid Therapy Solutions dominated the market in 2022, commanding the highest revenue share. Fluid therapy solutions are crucial for maintaining hydration and electrolyte balance in animals, especially during medical treatments, surgeries, and critical care. These solutions contain various electrolytes and fluids to support the overall health and recovery of animals. As veterinarians increasingly recognize the importance of fluid therapy in improving patient outcomes, the demand for fluid therapy solutions is expected to remain robust during the forecast period of 2023 to 2031. However, the highest CAGR during the forecast period is projected for the Electrolyte Solutions segment. Electrolyte solutions are specifically formulated to address electrolyte imbalances in animals, which can occur due to dehydration, illness, or certain medical conditions. The growing prevalence of conditions that result in electrolyte imbalances and the increasing awareness of the benefits of electrolyte therapy contribute to the segment's rapid growth. As veterinarians focus on the timely and accurate management of electrolyte imbalances to enhance animal health and recovery, the demand for electrolyte solutions is anticipated to surge.

End-Use Segment: Veterinary Clinics Dominate the Market

The Veterinary Intravenous (IV) Solutions market can also be segmented based on its end-use applications, which encompass Veterinary Clinics, Animal Hospitals, Research Laboratories, and Others. Among these segments, Veterinary Clinics dominated in terms of highest revenue in 2022. Veterinary clinics play a vital role in providing primary and preventive care to animals, and intravenous solutions are commonly used to support treatments and medical procedures. The accessibility and convenience of veterinary clinics for routine treatments and minor surgeries drive the demand for IV solutions in this segment. As the number of veterinary clinics continues to grow, the demand for IV solutions in these settings is expected to maintain a substantial revenue share during the forecast period. However, the highest CAGR during the forecast period is projected for the Animal Hospitals segment. Animal hospitals are equipped to handle more complex medical cases and critical care, often requiring intravenous therapies for various conditions. With the rising prevalence of chronic diseases in animals and an increase in specialized veterinary care, the demand for IV solutions in animal hospitals is expected to witness significant growth. As animal hospitals focus on advanced treatment options and comprehensive medical services, the adoption of IV solutions for critical cases is likely to drive the segment's growth.

Market Competition to Intensify during the Forecast Period

The Veterinary Intravenous (IV) Solutions market is highly competitive, with several key players vying for market share. These players include leading manufacturers of veterinary medical products, pharmaceutical companies, and specialized animal health providers. Some of the top players in the market include Zoetis Inc., Bayer Animal Health, Merck & Co., Inc., Elanco Animal Health, and Boehringer Ingelheim Animal Health, among others. These companies have established a strong presence in the veterinary healthcare industry through their advanced research and development capabilities, diversified product portfolios, and global distribution networks. To maintain their competitive edge, these top players focus on key strategies such as technological advancements, strategic acquisitions, and expanding their geographic reach. Investing in state-of-the-art manufacturing technologies and research facilities allows them to develop innovative IV solutions that cater to the specific needs of different animal species and medical conditions. By offering a wide range of high-quality IV solutions for various veterinary applications, these companies aim to meet the diverse demands of veterinarians and pet owners. Furthermore, top players in the Veterinary Intravenous (IV) Solutions market closely monitor regulatory developments related to animal health and veterinary care. Adhering to evolving regulatory standards and implementing sustainable practices aligns them with global sustainability goals and enhances their reputation as environmentally responsible companies. As the demand for veterinary IV solutions continues to rise in both established and emerging markets, these key players are well-positioned to capitalize on the growth opportunities and contribute to the development of a more sustainable and resource-efficient veterinary healthcare supply chain.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofVeterinary Intravenous (IV) Solutions market are as follows:
Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Veterinary Intravenous (IV) Solutions market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Isotonic crystalloids
  • Synthetic colloids
  • Blood products
  • Dextrose solutions
  • Parenteral nutrition
Indication
  • Diabetic Ketoacidosis
  • Pancreatitis
  • Anthrax
  • Chronic Kidney Disease
  • Others
Animal Type
  • Companion Animals
  • Production Animals
End-Use
  • Veterinary Hospitals
  • Research Institutes
  • Others

Region Segment (2021 - 2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Veterinary Intravenous (IV) Solutions market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Veterinary Intravenous (IV) Solutions market?
  • Which is the largest regional market for Veterinary Intravenous (IV) Solutions market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Veterinary Intravenous (IV) Solutions market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Veterinary Intravenous (IV) Solutions market worldwide?

This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Veterinary Intravenous (IV) Solutions Market
2.2. Global Veterinary Intravenous (IV) Solutions Market, By Product, 2022 (US$ Million)
2.3. Global Veterinary Intravenous (IV) Solutions Market, By Indication, 2022 (US$ Million)
2.4. Global Veterinary Intravenous (IV) Solutions Market, By Animal Type, 2022 (US$ Million)
2.5. Global Veterinary Intravenous (IV) Solutions Market, By End-Use, 2022 (US$ Million)
2.6. Global Veterinary Intravenous (IV) Solutions Market, By Geography, 2022 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2022
3. Veterinary Intravenous (IV) Solutions Market: Competitive Analysis
3.1. Market Positioning of Key Veterinary Intravenous (IV) Solutions Market Vendors
3.2. Strategies Adopted by Veterinary Intravenous (IV) Solutions Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Veterinary Intravenous (IV) Solutions Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Veterinary Intravenous (IV) Solutions Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Isotonic crystalloids
5.3.2. Synthetic colloids
5.3.3. Blood products
5.3.4. Dextrose solutions
5.3.5. Parenteral nutrition
6. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Diabetic Ketoacidosis
6.3.2. Pancreatitis
6.3.3. Anthrax
6.3.4. Chronic Kidney Disease
6.3.5. Others
7. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Companion Animals
7.3.2. Production Animals
8. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. Veterinary Hospitals
8.3.2. Research Institutes
8.3.3. Others
9. North America Veterinary Intravenous (IV) Solutions Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
9.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
9.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
9.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
9.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2021-2031, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
9.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
9.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
9.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
9.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
9.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
9.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
9.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
9.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
9.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
10. UK and European Union Veterinary Intravenous (IV) Solutions Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
10.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
10.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
10.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
10.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2021-2031, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
10.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
10.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
10.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
10.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
10.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
10.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
10.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
10.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
10.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
10.6.1.4.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
10.6.1.4.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
10.6.1.4.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
10.6.1.5. France
10.6.1.5.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
10.6.1.5.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
10.6.1.5.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
10.6.1.5.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
10.6.1.6.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
10.6.1.6.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
10.6.1.6.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
11. Asia Pacific Veterinary Intravenous (IV) Solutions Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
11.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
11.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
11.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
11.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2021-2031, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
11.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
11.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
11.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
11.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
11.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
11.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
11.6.1.3. India
11.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
11.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
11.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
11.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
11.6.1.4.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
11.6.1.4.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
11.6.1.4.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
11.6.1.5.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
11.6.1.5.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
11.6.1.5.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
11.6.1.6.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
11.6.1.6.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
11.6.1.6.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
12. Latin America Veterinary Intravenous (IV) Solutions Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
12.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
12.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
12.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
12.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2021-2031, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
12.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
12.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
12.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
12.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
12.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
12.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
12.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
12.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
12.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
13. Middle East and Africa Veterinary Intravenous (IV) Solutions Market, 2021-2031, USD (Million)
13.1. Market Overview
13.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
13.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
13.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
13.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
13.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2021-2031, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
13.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
13.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
13.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
13.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
13.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
13.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2021-2031, USD (Million)
13.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2021-2031, USD (Million)
13.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2021-2031, USD (Million)
13.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2021-2031, USD (Million)
14. Company Profile
14.1. Zoetis Inc.
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Bayer Animal Health
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Merck & Co., Inc.
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Elanco Animal Health
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. Boehringer Ingelheim Animal Health
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Dechra Veterinary Products
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Sypharma
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. Animalcare
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. B. Braun SE
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Woods Consulting, LLC
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Baxter
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. Fresenius Kabi
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
14.13. Other Notable Players
14.13.1. Company Overview
14.13.2. Financial Performance
14.13.3. Product Portfolio
14.13.4. Strategic Initiatives
List of Figures
Figure 1 Global Veterinary Intravenous (IV) Solutions Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Veterinary Intravenous (IV) Solutions Market: Quality Assurance
Figure 5 Global Veterinary Intravenous (IV) Solutions Market, By Product, 2022
Figure 6 Global Veterinary Intravenous (IV) Solutions Market, By Indication, 2022
Figure 7 Global Veterinary Intravenous (IV) Solutions Market, By Animal Type, 2022
Figure 8 Global Veterinary Intravenous (IV) Solutions Market, By End-Use, 2022
Figure 9 Global Veterinary Intravenous (IV) Solutions Market, By Geography, 2022
Figure 10 Market Geographical Opportunity Matrix - Global Veterinary Intravenous (IV) Solutions Market, 2022
Figure 11 Market Positioning of Key Veterinary Intravenous (IV) Solutions Market Players, 2022
Figure 12 Global Veterinary Intravenous (IV) Solutions Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 13 Global Veterinary Intravenous (IV) Solutions Market, By Product, 2022 Vs 2031, %
Figure 14 Global Veterinary Intravenous (IV) Solutions Market, By Indication, 2022 Vs 2031, %
Figure 15 Global Veterinary Intravenous (IV) Solutions Market, By Animal Type, 2022 Vs 2031, %
Figure 16 Global Veterinary Intravenous (IV) Solutions Market, By End-Use, 2022 Vs 2031, %
Figure 17 U.S. Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 18 Canada Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 19 Rest of North America Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 20 UK Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 21 Germany Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 22 Spain Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 23 Italy Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 24 France Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 25 Rest of Europe Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 26 China Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 27 Japan Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 28 India Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 29 Australia Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 30 South Korea Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 31 Rest of Asia Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 32 Brazil Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 33 Mexico Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 34 Rest of Latin America Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 35 GCC Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 36 Africa Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
Figure 37 Rest of Middle East and Africa Veterinary Intravenous (IV) Solutions Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 2 Global Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 3 Global Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 4 Global Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 5 North America Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 6 North America Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 7 North America Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 8 North America Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 9 U.S. Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 10 U.S. Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 11 U.S. Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 12 U.S. Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 13 Canada Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 14 Canada Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 15 Canada Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 16 Canada Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 17 Rest of North America Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 18 Rest of North America Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 19 Rest of North America Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 20 Rest of North America Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 21 UK and European Union Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 22 UK and European Union Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 23 UK and European Union Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 24 UK and European Union Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 25 UK Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 26 UK Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 27 UK Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 28 UK Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 29 Germany Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 30 Germany Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 31 Germany Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 32 Germany Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 33 Spain Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 34 Spain Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 35 Spain Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 36 Spain Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 37 Italy Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 38 Italy Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 39 Italy Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 40 Italy Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 41 France Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 42 France Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 43 France Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 44 France Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 45 Rest of Europe Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 46 Rest of Europe Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 47 Rest of Europe Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 48 Rest of Europe Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 49 Asia Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 50 Asia Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 51 Asia Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 52 Asia Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 53 China Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 54 China Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 55 China Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 56 China Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 57 Japan Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 58 Japan Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 59 Japan Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 60 Japan Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 61 India Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 62 India Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 63 India Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 64 India Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 65 Australia Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 66 Australia Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 67 Australia Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 68 Australia Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 69 South Korea Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 70 South Korea Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 71 South Korea Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 72 South Korea Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 73 Latin America Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 74 Latin America Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 75 Latin America Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 76 Latin America Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 77 Brazil Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 78 Brazil Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 79 Brazil Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 80 Brazil Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 81 Mexico Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 82 Mexico Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 83 Mexico Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 84 Mexico Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 85 Rest of Latin America Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 86 Rest of Latin America Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 87 Rest of Latin America Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 88 Rest of Latin America Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 89 Middle East and Africa Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 90 Middle East and Africa Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 91 Middle East and Africa Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 92 Middle East and Africa Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 93 GCC Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 94 GCC Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 95 GCC Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 96 GCC Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 97 Africa Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 98 Africa Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 99 Africa Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 100 Africa Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)
Table 101 Rest of Middle East and Africa Veterinary Intravenous (IV) Solutions Market By Product, 2021-2031, USD (Million)
Table 102 Rest of Middle East and Africa Veterinary Intravenous (IV) Solutions Market By Indication, 2021-2031, USD (Million)
Table 103 Rest of Middle East and Africa Veterinary Intravenous (IV) Solutions Market By Animal Type, 2021-2031, USD (Million)
Table 104 Rest of Middle East and Africa Veterinary Intravenous (IV) Solutions Market By End-Use, 2021-2031, USD (Million)

Companies Mentioned

  • Zoetis Inc.
  • Bayer Animal Health
  • Merck & Co., Inc.
  • Elanco Animal Health
  • Boehringer Ingelheim Animal Health
  • Dechra Veterinary Products
  • Sypharma
  • Animalcare
  • B. Braun SE
  • Woods Consulting, LLC
  • Baxter
  • Fresenius Kabi

Related Topics

Related Reports

Veterinary Intravenous (IV) Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Veterinary Intravenous (IV) Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Veterinary Intravenous (IV) Solutions Market Report 2025 - Product Image

Veterinary Intravenous (IV) Solutions Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Veterinary Intravenous Solutions Market Size, Share & Trends Analysis Report by Product, Animal Type (Companion Animals, Production Animals), Indication, End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Veterinary Intravenous Solutions Market Size, Share & Trends Analysis Report by Product, Animal Type (Companion Animals, Production Animals), Indication, End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.